Infezioni in Medicina最新文献

{"title":"Clinical pharmacology of the SingleTablet Regimen (STR) Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF).","authors":"Giovanni Di Perri","doi":"10.53854/liim-3103-3","DOIUrl":"https://doi.org/10.53854/liim-3103-3","url":null,"abstract":"<p><p>In Italy a proportion of HIV patients exceeding 50% are diagnosed at advanced stages of disease. A sizeable proportion of patients under chronic HIV treatment has a story of poor adherence with archived resistance associated mutations, a condition implying some risks in case of treatment with dual regimens. Conventional three-drug regimens will remain necessary in the short-mid term, in order to avoid treatment failure and selection of drug resistance. Efficacy, tolerability, safety, genetic barrier, forgiveness and a good compatibility with concurrent medications are all features that describe the overall quality of BIC/FTC/TAF, a combination whose robustness will remain a point of reference for the next years.</p>","PeriodicalId":52423,"journal":{"name":"Infezioni in Medicina","volume":"31 3","pages":"283-289"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495063/pdf/1124-9390_31_3_2023_283-289.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10606813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of COVID-19 pandemic on healthcare-associated infections, antibiotic resistance and consumption rates in intensive care units.","authors":"Uğur Önal,&nbsp;Ülkü Tüzemen,&nbsp;Esra Kazak,&nbsp;Neval Gençol,&nbsp;Esma Souleiman,&nbsp;Habibe İmer,&nbsp;Yasemin Heper,&nbsp;Emel Yılmaz,&nbsp;Cüneyt Özakın,&nbsp;Beyza Ener,&nbsp;Halıs Akalin","doi":"10.53854/liim-3102-7","DOIUrl":"https://doi.org/10.53854/liim-3102-7","url":null,"abstract":"<p><strong>Purpose: </strong>This paper aimed to evaluate the effects of the COVID-19 pandemic on healthcare-associated infections (HAIs), antibiotic resistance and consumption rates in intensive care units (ICUs) of a tertiary care university hospital.</p><p><strong>Patients and methods: </strong>Between 1 January 2018 and 31 December 2021, adult patients diagnosed with HAIs in ICUs were investigated retrospectively. Patients were divided into pre-pandemic (2018-2019) and pandemic periods (2020-2021). Antibiotic consumption index was calculated via using the formula of (total dose (grams)/defined daily dose (DDD) x total patient days) x1000. A p value below 0.05 was accepted as statistically significant.</p><p><strong>Results: </strong>The incidence of HAIs (per 1000 patient days) in the ICU of COVID-19 patients was 16.59, while it was 13.42 in the other ICUs during the pandemic period (p=0.107). The bloodstream infection (BSI) incidence was 3.32 in the pre-pandemic period and 5.41 in the pandemic period in ICUs other than the ICU of COVID-19 patients (p<0.001). In the pandemic period, the BSI incidence rate was significantly higher in the ICU of COVID-19 patients than in the other ICUs (14.26 vs 5.41, p<0.001). Central venous catheter bloodstream infections incidence rate was 4.72 in the pre-pandemic and 7.52 in the pandemic period in ICUs other than the ICU of COVID-19 patients (p=0.0019). During the pandemic period, the bacteraemia episode rates of <i>Acinetobacter baumannii</i> (5.375 vs 0.984, p<0.001), <i>Enterococcus spp</i>. (1.635 vs 0.268, p<0.001) and <i>Stenotrophomonas maltophilia</i> (3.038 vs 1.297, p=0.0086) in the ICU of COVID-19 patients were significantly found higher than others. The extended-spectrum beta-lactamase (ESBL) positivity rates for <i>Klebsiella pneumoniae</i> and <i>Escherichia coli</i> were 61% and 42% in the pre-pandemic period; 73% and 69% in the pandemic period in ICUs other than the ICU of COVID-19 patients (p>0.05). In the pandemic period, the ESBL positivity rates for <i>K. pneumoniae</i> and <i>E. coli</i> were 83% and 100% in the ICU of COVID-19 patients, respectively. Meropenem (p<0.001), teicoplanin (p<0.001) and ceftriaxone (p<0.001) consumptions were increased while ciprofloxacin (p=0.003) consumption was decreased in all ICUs after the pre-pandemic period.</p><p><strong>Conclusions: </strong>BSI and CVCBSI incidence rates were significantly increased in all ICUs after the COVID-19 pandemic in our hospital. Bacteraemia episode rates of <i>A. baumannii</i>, Enterococcus spp. and <i>S. maltophilia</i> in ICU of COVID-19 patients were significantly found higher than others. In addition, meropenem, teicoplanin and ceftriaxone consumptions were increased in all ICUs after the COVID-19 pandemic.</p>","PeriodicalId":52423,"journal":{"name":"Infezioni in Medicina","volume":"31 2","pages":"195-203"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241394/pdf/1124-9390_31_1_2023_195-203.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9589419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dracunculiasis over the centuries: the history of a parasite unfamiliar to the West.","authors":"Omar Simonetti,&nbsp;Verena Zerbato,&nbsp;Stefano Di Bella,&nbsp;Roberto Luzzati,&nbsp;Fabio Cavalli","doi":"10.53854/liim-3102-15","DOIUrl":"https://doi.org/10.53854/liim-3102-15","url":null,"abstract":"<p><p>Dracunculiasis (Guinea Worm Disease) is a terrible disease limited, even historically, to the arid and poor areas of our planet and which in the West has always been seen as an exotic disease and therefore has never taken root in the collective imagination. This parasitosis is transmitted to humans by drinking water contaminated with crustacean harboring larvae of <i>Dracunculus</i> <i>m</i><i>edinensis</i>, a nematode. The natural history of the disease is caused by adult worms invading connective tissues and causing blistering, ulceration and edema. Well known in Ancient Egypt where the disease was endemic in its southern area, was known in Europe mainly from the reports of medical writers starting from the Roman imperial period but without direct knowledge. In Middle age the descriptions of this disease that physicians and surgeons could read on medical books, at the end, were attributed to veterinary parasitic disease. In Modern age only during the colonialist era dracunculiasis was perceived as a problem, however sporadic. In 1986 Guinea Worm Eradication Program (GWEP) was launch without success. Thus, the disappearance of this parasitosis should still be postponed but not abandoned.</p>","PeriodicalId":52423,"journal":{"name":"Infezioni in Medicina","volume":"31 2","pages":"257-264"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241402/pdf/1124-9390_31_1_2023_257-264.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9644582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Response to BNT162b2 mRNA COVID-19 vaccine of ART-experienced people living with HIV: a prospective analysis from a single-center study in Rome, Italy.","authors":"Francesca Lombardi,&nbsp;Simone Belmonti,&nbsp;Simona Di Giambendetto","doi":"10.53854/liim-3103-9","DOIUrl":"https://doi.org/10.53854/liim-3103-9","url":null,"abstract":"<p><strong>Objectives: </strong>We aimed to assess the immunologic response to BNT162b2 mRNA COVID-19 vaccine in ART-experienced people living with HIV (PLWH). Methods: In this pilot prospective study, we enrolled 20 PLWH (all on effective ART, 80% with CD4 cells count >500) and 52 immunocompetent health-care workers, as control. All subjects received two doses of vaccine 21 days apart. Serum samples were collected at different time points, immediately before first administration (BL) and 21 days after each dose (T1 and T2) and 45-50 days after second dose (T3). We evaluated the immune response in terms of frequency of responders and antibody titers against SARS-CoV-2 at each timepoint. The viro-immunological parameters of PLWH were also monitored.</p><p><strong>Results: </strong>We found that the participants displayed an immune response after the first dose that increased markedly at T2. At T3 a significantly descending trend of IgG levels was observed in both groups. No difference in humoral immune response assessed in terms of percentage of responders after first and second dose and in terms of IgG titers over time and at each time point was found between groups. Any significant variation in terms of viremia and immunological parameters was observed in PLWH.</p><p><strong>Conclusions: </strong>BNT162b2 mRNA COVID-19 vaccine appears immunogenic in this setting of PLWH eliciting an immune response comparable to that of healthy donors.</p>","PeriodicalId":52423,"journal":{"name":"Infezioni in Medicina","volume":"31 3","pages":"359-363"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495060/pdf/1124-9390_31_3_2023_359-363.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10606808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The sources of antimicrobial peptides against Gram-positives and Gramnegatives: our research experience.","authors":"Giulio Rizzetto,&nbsp;Daisy Gambini,&nbsp;Andrea Maurizi,&nbsp;Elisa Molinelli,&nbsp;Edoardo De Simoni,&nbsp;Francesco Pallotta,&nbsp;Lucia Brescini,&nbsp;Oscar Cirioni,&nbsp;Annamaria Offidani,&nbsp;Oriana Simonetti,&nbsp;Andrea Giacometti","doi":"10.53854/liim-3103-5","DOIUrl":"https://doi.org/10.53854/liim-3103-5","url":null,"abstract":"<p><p>Antibiotic resistance of Gram-positive and Gramnegative bacteria is becoming increasingly prevalent. For this reason, the search for new molecules that can overcome current resistance and also recover antibiotics that are no longer effective is becoming increasingly urgent. Our research group at the 'Polytechnic University of Marche' managed to study the effectiveness of certain antimicrobial peptides (AMPs). We decided to review our experience with AMPs by classifying them according to their origin and evaluating their effect on Gram-negative and Gram-positive bacteria. AMPs can derive from mammals, amphibians, microorganisms, and insects. In conclusion, our research experience shows that the richest source of AMPs are amphibians. However, the studies done are mainly in vitro or in animal models, requiring further human studies to assess the efficacy and safety of these molecules. AMPs may be a new therapeutic option for infections sustained by multi-resistant micro-organisms and for overcoming the mechanisms of resistance to antibiotics currently used. In particular, combining AMPs with antibiotics, including those with limited antimicrobial activity due to antimicrobial resistance, has often shown a synergistic effect, increasing or restoring their efficacy. The possibility of using manageable and relatively safe antibiotics again is crucial, considering the widespread increase in bacterial resistance in hospitals and the community. Despite a plethora of research on AMPs and their application as potential treatment on infectious diseases, this area needs further exploration. There is evidence that the characteristics of AMPs can seriously improve through structural chemical modifications and different delivery systems to become alternatives drugs to conventional antibiotics. The aim is to provide an overview of the possible sources from which AMPs are extracted, evaluating their action exclusively on Gram-positive and negative bacteria. This is to determine, based on our experience, which might be the most promising sources of AMPs for future research as well.</p>","PeriodicalId":52423,"journal":{"name":"Infezioni in Medicina","volume":"31 3","pages":"306-322"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495054/pdf/1124-9390_31_3_2023_306-322.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10606814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparative study of pandemics and their impact on children and adolescents: COVID-19 and Spanish Flu.","authors":"Sofia Dalekou,&nbsp;Spyros N Michaleas,&nbsp;Artemis K Tsitsika,&nbsp;Marianna Karamanou","doi":"10.53854/liim-3102-1","DOIUrl":"https://doi.org/10.53854/liim-3102-1","url":null,"abstract":"<p><strong>Overview: </strong>Pandemics are characterized by an abrupt and sudden outburst and absence of preparation for its management. The focus during pandemics is on the medical aspect of the disease and not on its impact on the citizens' or vulnerable groups' psychosocial wellbeing.</p><p><strong>Aim: </strong>The purpose of this study was to highlight the impact of the pandemics of the Spanish Flu and COVID-19 on children and adolescents as well as to recognize their short and long-terms effects on children's and adolescents' physical and mental health.</p><p><strong>Materials and methods: </strong>The material of this review constituted of publications regarding the impact of the Spanish Flu and COVID-19 on children and adolescents via relative search through valid databases and websites of trustworthy organizations.</p><p><strong>Results: </strong>The main finding of the present review was that pandemics negatively affect children and adolescents undermining their mental and physical health. The factors that negatively impact on this population's normal development include parental death, financial hardships, restrictive measures, disruption of daily routine and absence of social contact. The short-term effects include anxiety, depression, aggressive behavior as well as fear and grief. Mental disorders, disability, poor academic performance and low socioeconomic level are among the long-term effects of the two under study pandemics.</p><p><strong>Conclusions: </strong>Children and adolescents constitute a vulnerable group amidst pandemics and there is a need for coordinated worldwide and national actions to prevent and timely manage a pandemic's impact.</p>","PeriodicalId":52423,"journal":{"name":"Infezioni in Medicina","volume":"31 2","pages":"131-139"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241393/pdf/1124-9390_31_1_2023_131-139.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9947159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cerebrovascular disease in COVID-19: a systematic review and meta-analysis.","authors":"Ritesh G Menezes,&nbsp;Tamim Omar Alabduladhem,&nbsp;Ahmed Kamal Siddiqi,&nbsp;Muhammad Talha Maniya,&nbsp;Abdulaziz Mazen Al Dahlawi,&nbsp;Mohammed Waleed Abdulaziz Almulhim,&nbsp;Hadeel Waleed Almulhim,&nbsp;Yasmeen Abdulwahab Ali Saeed,&nbsp;Moath Saad Alotaibi,&nbsp;Sarah Saud Alarifi,&nbsp;Abdulrahman Mohammed Alkathiry,&nbsp;Talal Almas","doi":"10.53854/liim-3102-2","DOIUrl":"https://doi.org/10.53854/liim-3102-2","url":null,"abstract":"<p><strong>Background: </strong>The association between COVID-19 and acute cerebrovascular disease (CVD) has not been explored extensively. New data has come to light which may change previous results.</p><p><strong>Methods: </strong>We queried the PubMed electronic database from its inception until February 2022 for studies evaluating the incidence of stroke in COVID-19 patients. Results of the analysis were pooled using a random-effects model and presented as odds ratios (ORs) with 95% confidence intervals (95% CIs).</p><p><strong>Results: </strong>37 studies consisting of 294,249 patients were included in our analysis. Pooled results show that the incidence of acute CVD events in COVID-19 positive patients is 2.6% (95% CI: 2.0-3.3; P<0.001). Cardioembolic (OR=14.15, 95% CI: 11.01 to 18.19, P<0.00001) and cryptogenic (OR=2.87, 95% CI: 1.91 to 4.32, P<0.00001) etiologies were associated with COVID-19 positivity. Risk factors for CVD events in patients with COVID-19 were atrial fibrillation (OR=2.60, 95% CI: 1.15 to 5.87, P=0.02), coronary artery disease (OR=2.24, 95% CI: 1.38 to 3.61, P=0.0010), diabetes (OR=2.46, 95% CI: 1.36 to 4.44, P=0.003) and hypertension (OR=3.65, 95% CI: 1.69 to 7.90, P=0.005).</p><p><strong>Conclusion: </strong>COVID-19 infection is associated with an increased risk for acute CVD and is associated with cardioembolic and cryptogenic etiologies and the risk factors of atrial fibrillation, coronary artery disease, diabetes and hypertension in COVID-19 positive patients.</p>","PeriodicalId":52423,"journal":{"name":"Infezioni in Medicina","volume":"31 2","pages":"140-150"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241400/pdf/1124-9390_31_1_2023_140-150.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9644580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Update on Mpox: a brief narrative review.","authors":"Spinello Antinori,&nbsp;Giacomo Casalini,&nbsp;Andrea Giacomelli,&nbsp;Alfonso J Rodriguez-Morales","doi":"10.53854/liim-3103-1","DOIUrl":"https://doi.org/10.53854/liim-3103-1","url":null,"abstract":"<p><p>Mpox (formerly Monkeypox), a neglected tropical disease once confined to Central and West Africa, emerged as a global epidemic outbreak in May, 2022 with 87,529 cases reported as of May, 23, 2023. It predominantly affected men (96.2%) who have sex with men (84-100%), although other transmission routes have been reported, including occupational exposure and vertical transmission. Concomitant HIV infection has been recorded in 21-46.9% and pre-exposure prophylaxis against HIV infection has been reported in 11-57% of published cases. The current outbreak clinical presentation differs from endemic cases with prodromal symptoms that could be absent: the number of lesions is generally low, with skin lesions predominantly localised in the ano-genital areas and frequent lesions present in different stages of progression (i.e., asynchronous). Asymptomatic Mpox infection can occur in 1.8-6.5% of at-risk subjects. People living with HIV with severe immunodeficiency (less than 100 CD4+ lymphocytes per microliter) are at risk of more severe clinical manifestations and death. According to a systematic review and meta-analysis, the hospitalisation rate is around 6% and the observed case-fatality rate is less than 0.1%. Tecovirimat is the drug of choice for treating severe cases although there is no evidence of efficacy from randomised controlled trials. Immunization with a live non-replicating vaccine (JYNNEOS) effectively reduces the disease's incidence.</p>","PeriodicalId":52423,"journal":{"name":"Infezioni in Medicina","volume":"31 3","pages":"269-276"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495048/pdf/1124-9390_31_3_2023_269-276.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10606810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Zoonotic febrile illnesses misdiagnosed as COVID-19: a review of reported clinical cases.","authors":"Carlos Ramiro Silva-Ramos,&nbsp;Julián A Mejorano-Fonseca,&nbsp;Alfonso J Rodríguez-Morales,&nbsp;Marylin Hidalgo,&nbsp;Álvaro A Faccini-Martínez","doi":"10.53854/liim-3102-3","DOIUrl":"https://doi.org/10.53854/liim-3102-3","url":null,"abstract":"<p><p>COVID-19 is a zoonotic coronavirus disease caused by SARS-CoV-2. Its fast spreading by aerosol transmission has made it a highly contagious disease, causing the most recent 2020 pandemic. Although it mainly affects the respiratory system, atypical forms of the disease have been described, including developing an undifferentiated febrile illness without respiratory symptoms, that can represent a diagnostic challenge, mainly in tropical areas where several zoonotic febrile diseases are circulating. Thus, despite the broad clinical spectrum of COVID-19, in the tropics, other zoonotic etiologies should always be considered as differential diagnoses. According to our case reports review, eight different zoonotic febrile diseases misdiagnosed as COVID-19 have been reported in the available scientific literature of four databases. These were only suspected due to the epidemiological history. Thus, making a complete and detailed clinical history of a febrile patient in the tropics is essential to suspect the etiology and request the necessary confirmatory tests. Therefore, COVID-19 must be included as a differential diagnosis of undifferentiated febrile illness in the tropics, but other zoonotic infectious diseases must not be ruled out.</p>","PeriodicalId":52423,"journal":{"name":"Infezioni in Medicina","volume":"31 2","pages":"151-162"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241406/pdf/1124-9390_31_1_2023_151-162.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9589426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevention of congenital Chagas disease by screening of mothers and monitoring of serological tests of neonates: the seven years' experience.","authors":"Annibale Raglio,&nbsp;Libera Clemente,&nbsp;Davide Guarneri,&nbsp;Marco Arosio,&nbsp;Marzia Maino,&nbsp;Luisa Patanè,&nbsp;Marco Cavallini,&nbsp;Paola Rodari,&nbsp;Giovanna Mangili,&nbsp;Claudio Farina","doi":"10.53854/liim-3102-13","DOIUrl":"https://doi.org/10.53854/liim-3102-13","url":null,"abstract":"<p><p>Approximately 14000 immigrants coming from the Cochabamba area of Bolivia, with an increased risk of congenital Chagas Disease (CD), are currently living in Bergamo, Italy. According to the World Health Organization (WHO) recommendation (2011), prevention of congenital CD involves testing all pregnant women at risk of infection and performing follow-up of their newborns. In our study, all pregnant women of Latin American origin were tested for the presence of <i>Trypanosoma cruzi</i> antibodies and children, born to mothers found to be positive, were followed up after delivery. <i>T. cruzi</i> antibodies were detected using a chemiluminescence immunoassay. The test was also performed on siblings and fathers of children with CD, and women of childbearing age to prevent the congenital infection, as proposed by 2011 WHO recommendation. In the study period 1105 patients were tested for CD, using a serological test: 934 (85%) were females and 171 (15%) were males. Of the 62 newborns, from mothers who tested positive, 28 were females and 34 were males. The number of positive adults and siblings identified was 148 (14%). Among the adults and siblings born between 1991 and 2011 only 3 (2%) of females tested positive to serological test. All neonates, with the exception of one, were classified as non-infected according to the follow-up of index value of CD serology. This study confirms the usefulness of serological tests and of their index value as follow-up. The difference of positivity rate for CD antibodies between people born before and after 1990 should be further investigated to generate information that potentially improve the prevention and control of CD.</p>","PeriodicalId":52423,"journal":{"name":"Infezioni in Medicina","volume":"31 2","pages":"243-249"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241396/pdf/1124-9390_31_1_2023_243-249.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9592177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}